Related Experiment Videos
Neonatal sporadic hyperekplexia: a rare and often unrecognized entity
1Dipartimento di Pediatria, Università di Napoli Federico II, Italy.
Brain & Development
|April 1, 1997
Summary
Neonatal sporadic hyperekplexia causes transient stiffness and myoclonic jerks in newborns. Clobazam offers a novel, successful treatment for this rare neurological disorder.
Area of Science:
- Neurology
- Pediatrics
- Genetics
Background:
- Neonatal sporadic hyperekplexia is a rare genetic disorder characterized by exaggerated startle responses.
- Symptoms include generalized stiffness, increased muscle tone, and myoclonic jerks presenting from birth.
Observation:
- A newborn infant presented with transient generalized stiffness and myoclonic jerks evident from the first days of life.
- Initial treatment with phenobarbital was ineffective in managing the infant's symptoms.
Findings:
- The infant was diagnosed with neonatal sporadic hyperekplexia.
- Successful treatment was achieved using clobazam, a 1,5-dibenzodiazepine, marking a novel therapeutic approach.
Implications:
- This case highlights clobazam as a potential effective treatment for neonatal sporadic hyperekplexia.
- Further research into benzodiazepine efficacy for hyperekplexia is warranted.